What stage does NSG Ventures invest at?

NSG Ventures invests at the Seed, Series A stages.

What sectors does NSG Ventures focus on?

NSG Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.

Where is NSG Ventures located?

NSG Ventures is headquartered in Singapore, SG.

NSG Ventures

Venture capital

Singapore · Seed–Series A · 9 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

NSG Ventures focuses on biotechnology and the treatment of human disease, investing in innovative scientific solutions to major health problems. Managed by founders and scientists, the firm partners with exceptional teams for the long term to push scientific boundaries and enable medical breakthroughs.

Invests inBiotech Digital Health Healthtech Medical DevicesAsia-PacificChinaGlobalNorth AmericaSingaporeSingaporeUnited States

Source: firm website, verified Aug 3, 2026.

Stage

Seed–Series A

Singapore, SG

Instruments

Equity

Founded

2021

Tracked investments

Team · 9 people

from the firm's website & public directories

Jeffrey Lu· Founding Partner

Technology and healthcare entrepreneur who co-founded Engine Biosciences and held senior roles at AAE, AirAsia, Goodman Capital and Bain & Company. Has made investments across healthcare, biotech and internet companies. Graduated summa cum laude from the University of Pennsylvania.

Timothy Lu· Founding Partner

Synthetic biology expert and serial biotech entrepreneur serving as Chief Scientific Advisor of NSG Ventures. Co-founded multiple companies including Tango Therapeutics, Senti Biosciences, and Synlogic, and is an MIT professor. Holds an M.D. from Harvard and a Ph.D. from MIT.

Daphne Teo· Founding Partner

Founder and CEO of NSG Ventures and NSG BioLabs, with over a decade of experience across real estate, biotech, and investment banking. Co-founder of Engine Biosciences and Chief Investment Officer of D3 Capital, previously at Goldman Sachs and HSBC.

d•••@nsg.venturesreveal

Ken Nesmith· Venture Partner

Healthcare and life sciences technologist and executive; currently CBO of the oncology business at Lunit and formerly co-founder and CEO of Lexent Bio (acquired by Foundation Medicine). Completed studies at MIT and an MBA at Wharton.

Paul Lin· Venture Partner

Life sciences and technology executive with over 20 years' experience, formerly COO at Plexxikon where he led IND filing for vemurafenib/Zelboraf. Holds dual M.D. and M.B.A. degrees from the University of Pennsylvania.

Cheryl Cui· Advisor

Biomedical engineer focused on identifying promising technologies and working with founders. Former Venture Partner at VentureHealth and co-founder of an acquired mobile health company. Holds a joint PhD from MIT and Harvard Medical School.

Darin Baur· CFO

Corporate finance and legal executive with over 20 years' experience leading financings and M&A across Asia, the U.S., Australia and Europe. Began as an attorney at Skadden Arps and held investment banking roles at Citigroup, HSBC and Canaccord Genuity. Holds a J.D. from Harvard Law.

David Epstein· Advisor

Biopharmaceutical leader and founder of Black Diamond Therapeutics, which he took public on NASDAQ. Former Vice Dean of Innovation & Entrepreneurship at Duke-NUS and former CSO of OSI Pharmaceuticals. Holds a Ph.D. in Biochemistry from Brandeis University.

Fiona Lee· Advisor· Singapore

Trained bench scientist working across neuroscience, skin biology, stem cells and oncology who functions as an Investment Associate at NSG, performing due diligence and writing investment memos. Holds a DPhil from Oxford and a bachelor's from Imperial College London.

What they invest in

from 12 of 27 portfolio companies

Biotech ×10AI & Machine Learning ×4Deep Tech ×4Medical Devices ×4Digital Health ×2Fintech ×1PropTech ×1Robotics ×1

HQs:United States×4Brazil×1United Kingdom×1Singapore×1

Investments · 27 tracked

founders shown can be your intro path

BiomXbiomx.comin 𝕏NYSE: PHGE

Biotech

Jesse Goodman(Director)Alan Moses(Director)Jonathan Leff(Director)Jonathan Solomon(Chief Executive Officer)Merav Bassan(Chief Development Officer)Gregory Merril(Director)

Black Diamond Therapeutics, Incblackdiamondtherapeutics.comNASDAQ: BDTX

Senti Biosciencessentibio.comin 𝕏NASDAQ: SNTI

Senti Bio develops cell and gene therapies for cancer and difficult-to-treat diseases using synthetic biology and engineered Gene Circuits to enhance precision, control, and selectivity in targeting tumor cells.

BiotechDeep TechMedical DevicesSouth San Francisco, US

Tim Lu(Co-Founder and Chief Executive Officer)James Collins(Director)Kanya Rajangam(President, Head of Research & Development and Chief Medical Officer)Yvonne Li(Executive Officer)Philip Lee(Executive Officer)

BoardDonald Tang(Director)

Synlogicsynlogictx.comin 𝕏OTC: SYBX

Synlogic develops synthetic biology-based biotherapeutics that use engineered living organisms to treat diseases.

BiotechDeep TechMedical DevicesCambridge, US

Bharatt Chowrira(Executive Officer)Ankit Mahadevia(Director)Michael Sheahan(Executive Officer)Jose Carlos Gutierrez-Ramos(Executive Officer, Director)Lewis Geffen(Executive Officer)Paul Miller(Executive Officer)

Tango Therapeuticstangotx.comNASDAQ: TNGX

Tango Therapeutics develops genetically targeted medicines using synthetic lethality principles to treat specific tumors.

BiotechBoston, US

Adam Crystal(Executive Officer)Daniella Beckman(Executive Officer)Douglas Barry(Executive Officer)Alan Huang(Executive Officer)Aaron Davis(Director)

BoardBarbara Weber(Executive Officer, Director)

88 Rising

Aslanaslanpharma.com

Biotixbiotix.bio

Biotix develops natural, sustainable skincare ingredients derived from skin microbiome microbes, using an AI platform alongside biology experiments to identify and test ingredients for efficacy and safety.

AI & Machine LearningBiotechWellness & Fitness

Black Diamond

Bota Biobota.bio

Cognito Healthcognitohealth.comin

Cognito Health offers a contact-free predictive patient monitoring system that uses data insights and AI to detect fall risk, unassisted bed exits, and pressure injuries.

AI & Machine LearningDigital HealthMedical Devices

Corviumcorvium.com

Eligo Bioscienceeligo.bioin 𝕏

Engine Bioenginebio.com

Engine Bio presents itself as a company working on new cancer medicines.

Biotech

Enleofenenleofen.com

Foundation Medicinefoundationmedicine.comin 𝕏

Foundation Medicine is a precision medicine company that develops comprehensive genomic profiling and companion diagnostic tests for cancer and other diseases.

BiotechDigital HealthMedical DevicesBoston, US

Lexent

Lunitkedglobal.com

Medra AImedra.aiin 𝕏

Medra builds robotic systems integrated with AI, computer vision, and natural language processing to automate data collection for life science research.

AI & Machine LearningBiotechDeep TechRobotics

NSG Bionsgbio.comin

NSG Bio operates BSL-2 certified co-working wet-laboratory and office spaces for life sciences and biotech companies in Singapore, offering turnkey facilities, shared equipment, and support services for startups and multinationals conducting R&D.

BiotechPropTechSingapore, SG

Nubanknubank.com.brin 𝕏

Nubank is a digital bank offering checking accounts, credit cards, loans, and savings tools without annual fees or abusive charges.

FintechSão Paulo, BR

David Vélez(Founder)in

Open Proteinopenprotein.aiin 𝕏

OpenProtein.AI offers protein language models and AI infrastructure for protein engineering, covering de novo sequence design, variant effect prediction, in silico screening, and training specialized models on proprietary data.

AI & Machine LearningBiotechDeep Tech

Tristan Bepler

PairXBiopairxbio.com

Restorbiorestorbio.com

Senti

Tango

Zuzuzuzuhospitality.com

Exits · 5

IPOs and acquisitions across the tracked portfolio

BiomXNYSE: PHGEBlack Diamond Therapeutics, IncNASDAQ: BDTXSenti BiosciencesNASDAQ: SNTISynlogicOTC: SYBXTango TherapeuticsNASDAQ: TNGX

Portfolio news

latest coverage across their companies

Senti Biosciences (NASDAQ:SNTI) to spin off SENTI-202 pipeline to Celadon-backed NewCo via CVRs

Senti Biosciences · kalkine.com.au · Jul 31, 2026

Mizuho raises Tango Therapeutics stock price target on combo data By Investing.com

Tango Therapeutics · investing.com · Jul 17, 2026

Nu Holdings stock sees heavy turnover as Mexico bank approval meets valuation test

Nubank · ts2.tech · Jul 14, 2026

Medra Raises $52M, Partners With Genentech

Medra AI · hlth.com · Dec 15, 2025

Frequently asked questions

What stage does NSG Ventures invest at?: NSG Ventures invests at the Seed, Series A stages.
What sectors does NSG Ventures focus on?: NSG Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Where is NSG Ventures located?: NSG Ventures is headquartered in Singapore, SG.

Images

Similar investors

Amadeus Capital Partners

Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.

$50K – $12.7M

B Capital Group

B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.

$10M – $50M

Breyer Capital

Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.

$500K – $10M

DCVC (Data Collective)

DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.